This is a summary of the European public assessment report (EPAR) for DuoCover. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ... European Medicines Agency, 1 hour ago
Effect of Clopidogrel and Aspirin vs. Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: The CANOA Randomized Clinical Trial New-onset migraines affect approximately 15% of patients that have undergone ...2 Minute Medicine, 1 week ago Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: The CANOA Randomized Clinical Trial Journal of the American Medical Association, 2 weeks ago Clopidogrel and Aspirin vs Aspirin Alone in Treating Migraine Headaches Journal of the American Medical Association, 2 weeks ago
A recent study looked at the efficacy of clopidogrel, used in combination with aspirin, for the prevention of migraines after transcatheter atrial septal defect (ASD) closure. The randomized, double-blind study, conducted in six Canadian hospitals, ...Pharmacist.com, 2 weeks ago AHA: DAPT prevents migraines after atrial-septal defect closure PM 360, 1 day ago Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation American Heart Journal, 6 days ago AHA.15: Dual antiplatelet therapy following transcatheter ASD closure reduces number and severity of migraine headaches Cardiovascular Business, 1 week ago
Recent Studies from University Hospital Add New Data to Clopidogrel Therapy (Genetic and platelet function testing of antiplatelet therapy for...
Recent Studies from University Hospital Add New Data to Clopidogrel Therapy (Genetic and platelet function testing of antiplatelet therapy for percutaneous coronary intervention: the ARCTIC-GENE study) By a News Reporter-Staff News Editor at ...Pharmacy Choice, 1 week ago
Metabolic Interaction Potential between Clopidogrel and Sulfonylurea Antidiabetic Agents: Effects on Clopidogrel Bioactivation
Background: Patients with diabetes have increased rates of cardiovascular events, and concomitant use of antidiabetic agents and clopidogrel may increase the risk for drug interactions. This study was undertaken to investigate the interaction ...Karger.com, 1 week ago
FDA finds clopidogrel does not increase or decrease the risk of death in patients with heart disease
After an extensive review, the FDA found that the long-term use of clopidogrel does not increase or decrease the overall risk of death in patients with or at risk for heart disease. The FDA, which released its findings on Nov. 6, also said ...Cardiovascular Business, 1 week ago Long-Term Plavix Use Does Not Increase Death Risk Pharmacy Times, 2 weeks ago Plavix Does Not Increase the Risk of Cancer American Journal of Managed Care, 2 weeks ago
Prof-Research The 'Global and Chinese Clopidogrel Impurity Industry, 2010-2020 Market Research Report' is a professional and in-depth study on the current state of the global Clopidogrel Impurity industry with a focus on the Chinese market. The ...MarketResearch.com, 2 weeks ago
|Orthopedics Today, 2 weeks ago CANOA: Clopidogrel Reduces Migraine After ASD Closure MyInforms, 2 weeks ago|
Concurrent use of select PPIs could potentially decrease the antiplatelet effects of clopidogrel, study shows URL: http://www.aphadruginfoline.com/drug-interactions-corner/ppi%E2%80%93clopidogrel-interaction-concern-after-stent-placement ...Pharmacist.com, 2 weeks ago
Efficacy of Ex Vivo Autologous and In Vivo Platelet Transfusion in the Reversal of P2Y12 Inhibition by Clopidogrel, Prasugrel, and Ticagrelor: The APTITUDE Study [Pharmacology]Circulation: Cardiovascular Interventions, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!